CARDIOVASCULAR DISEASE IN COVID-19 PATIENTS. PART 2.
The COVID-19 pandemic caused by SARS-CoV-2 is the greatest medical problem of our time. The presence of concomitant cardiovascular pathology (CVD) in a patient predisposes to a severe course and the formation of adverse outcomes of COVID-19. It is currently known that SARS-CoV-2 infection leads, on the one hand, to exacerbation and decompensation of the patient's CVD, and, on the other hand, it is the origin of acute CVD. Understanding the impact of COVID-19 on the cardiovascular system is essential to provide comprehensive care for critically ill patients. In this review, we summarize the rapidly changing data on cardiovascular damage associated with COVID-19..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:19 |
|---|---|
| Enthalten in: |
Žurnal Grodnenskogo Gosudarstvennogo Medicinskogo Universiteta - 19(2021), 1, Seite 5-9 |
| Sprache: |
bel ; Englisch ; Russisch |
|---|
| Beteiligte Personen: |
Holyshko V. S. [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Coronavirus sars-cov-2 |
|---|
| doi: |
10.25298/2221-8785-2021-19-1-5-9 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ05089725X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ05089725X | ||
| 003 | DE-627 | ||
| 005 | 20230502233048.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230227s2021 xx |||||o 00| ||bel c | ||
| 024 | 7 | |a 10.25298/2221-8785-2021-19-1-5-9 |2 doi | |
| 035 | |a (DE-627)DOAJ05089725X | ||
| 035 | |a (DE-599)DOAJ9b7eaeafb6404db3aca3b97566e260e9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a bel |a eng |a rus | ||
| 100 | 0 | |a Holyshko V. S. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a CARDIOVASCULAR DISEASE IN COVID-19 PATIENTS. PART 2. |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a The COVID-19 pandemic caused by SARS-CoV-2 is the greatest medical problem of our time. The presence of concomitant cardiovascular pathology (CVD) in a patient predisposes to a severe course and the formation of adverse outcomes of COVID-19. It is currently known that SARS-CoV-2 infection leads, on the one hand, to exacerbation and decompensation of the patient's CVD, and, on the other hand, it is the origin of acute CVD. Understanding the impact of COVID-19 on the cardiovascular system is essential to provide comprehensive care for critically ill patients. In this review, we summarize the rapidly changing data on cardiovascular damage associated with COVID-19. | ||
| 650 | 4 | |a coronavirus sars-cov-2 | |
| 650 | 4 | |a myocardial damage | |
| 650 | 4 | |a pathology of the cardiovascular system | |
| 653 | 0 | |a Medicine | |
| 653 | 0 | |a R | |
| 700 | 0 | |a Snezhitskiy V. A. |e verfasserin |4 aut | |
| 700 | 0 | |a Matsiyeuskaya N. V. |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Žurnal Grodnenskogo Gosudarstvennogo Medicinskogo Universiteta |d Grodno State Medical University, 2018 |g 19(2021), 1, Seite 5-9 |w (DE-627)DOAJ000066737 |x 24130109 |7 nnns |
| 773 | 1 | 8 | |g volume:19 |g year:2021 |g number:1 |g pages:5-9 |
| 856 | 4 | 0 | |u https://doi.org/10.25298/2221-8785-2021-19-1-5-9 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/9b7eaeafb6404db3aca3b97566e260e9 |z kostenfrei |
| 856 | 4 | 0 | |u http://journal-grsmu.by/index.php/ojs/article/view/2424/2203 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2221-8785 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2413-0109 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 19 |j 2021 |e 1 |h 5-9 | ||